Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000085962 | SCV000491313 | pathogenic | not provided | 2023-06-22 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 8477259, 1642278, 7963676, 13680365, 25216246, 28266639, 19626598, 18463683, 31589614, 34426522, 33800529, 31816670) |
Fulgent Genetics, |
RCV000763290 | SCV000893937 | likely pathogenic | Tyrosinase-negative oculocutaneous albinism; Oculocutaneous albinism type 1B; Ocular albinism with congenital sensorineural hearing loss; SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Hadassah Hebrew University Medical Center | RCV000003999 | SCV001437671 | pathogenic | Tyrosinase-negative oculocutaneous albinism | 2019-06-20 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001332387 | SCV001524704 | uncertain significance | Oculocutaneous albinism type 1B | 2019-04-11 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. These variants have been previously reported as disease-causing [PMID 1642278, 28266639, 1903591, 27775880, 25333069, 21906913, 28667292, 24123366, 9242509, 11284711, 1429711] |
Genome- |
RCV000003999 | SCV001821903 | likely pathogenic | Tyrosinase-negative oculocutaneous albinism | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000085962 | SCV002121290 | pathogenic | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 217 of the TYR protein (p.Arg217Trp). This variant is present in population databases (rs63159160, gnomAD 0.04%). This missense change has been observed in individual(s) with ocular albinism (PMID: 1642278, 10987646, 27734839, 28266639). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 3795). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TYR protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003460422 | SCV004207563 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000085962 | SCV004700644 | pathogenic | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | TYR: PM3:Very Strong, PM2 |
OMIM | RCV000003999 | SCV000024165 | pathogenic | Tyrosinase-negative oculocutaneous albinism | 1992-07-15 | no assertion criteria provided | literature only | |
Retina International | RCV000085962 | SCV000118105 | not provided | not provided | no assertion provided | not provided | ||
University of Washington Center for Mendelian Genomics, |
RCV000755070 | SCV000882888 | likely pathogenic | Nonsyndromic Oculocutaneous Albinism | 2017-03-07 | no assertion criteria provided | research |